Drugs / Sulfonatoporphyrin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04371822 Comparator | Aug → Oct 2020 | COVID-19 | Kafrelsheikh University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulfonatoporphyrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04371822 ↗ |
| Known as | TPPS | “5 mg of sulfonatoporphyrin(TPPS), and They will be exposed to sunlight two hours every day for 14 days” NCT04371822 ↗ |